2021
DOI: 10.3390/cells10092249
|View full text |Cite
|
Sign up to set email alerts
|

Perfluorocarbon-Based Oxygen Carriers and Subnormothermic Lung Machine Perfusion Decrease Production of Pro-Inflammatory Mediators

Abstract: The quality of marginal donor lungs is clinically assessed with normothermic machine perfusion. Although subnormothermic temperature and perfluorocarbon-based oxygen carriers (PFCOC) have proven favourable for other organ transplants, their beneficial use for ex vivo lung perfusion (EVLP) still requires further investigation. In a rat model, we evaluated on a 4 h EVLP time the effects of PFCOC with either 28 °C or 37 °C perfusion temperatures. During EVLP at 28 °C with PFCOC, we recorded significantly lower lu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 44 publications
(62 reference statements)
0
6
0
Order By: Relevance
“…Previously, hyperbaric oxygen inhalation was regarded as a common medical strategy to alleviate tumor hypoxia. However, oxygenation of hyperbaric blood is hampered by the inefficiency of microvascular systems in tumor tissue and superfluous systemic oxygen inhalation would induce the probable toxicity, which further limits its clinical application. , Nowadays, researchers have proposed some novel design ideas to increase the concentration of O 2 at the tumor sites, including the construction of appropriate O 2 conveyors such as perfluorocarbon or hemoglobin to transport O 2 directly to the tumor tissue , and suppressing cell respiration to improve the O 2 level, which have obtained desirable outcomes in the animal experiments. Meantime, enzymes, such as the natural enzymes (catalase) and nanozymes (MnO 2 ), have been considered a new class of nanomedicine for in situ intratumoral oxygen generation.…”
Section: Introductionmentioning
confidence: 99%
“…Previously, hyperbaric oxygen inhalation was regarded as a common medical strategy to alleviate tumor hypoxia. However, oxygenation of hyperbaric blood is hampered by the inefficiency of microvascular systems in tumor tissue and superfluous systemic oxygen inhalation would induce the probable toxicity, which further limits its clinical application. , Nowadays, researchers have proposed some novel design ideas to increase the concentration of O 2 at the tumor sites, including the construction of appropriate O 2 conveyors such as perfluorocarbon or hemoglobin to transport O 2 directly to the tumor tissue , and suppressing cell respiration to improve the O 2 level, which have obtained desirable outcomes in the animal experiments. Meantime, enzymes, such as the natural enzymes (catalase) and nanozymes (MnO 2 ), have been considered a new class of nanomedicine for in situ intratumoral oxygen generation.…”
Section: Introductionmentioning
confidence: 99%
“…As already mentioned, several preclinical studies support the beneficial effects of alternative OCs in the field of ex-vivo organ perfusion (10,19,20,25,26,56,58). PFC-based OCs and M101 provide a high oxygen-carrying capacity and perform well in cell metabolism and histology with an amelioration of ischemiareperfusion injury (21,27).…”
Section: Discussionmentioning
confidence: 87%
“…Artificial oxygen carriers such as hemopure are an alternative to RBCs and are being trialled in kidney NMP ( 31 , 32 ). Subnormothermic temperatures or the combination of subnormothermic temperature and artificial oxygen carriers have recently been shown to reduce inflammation and pulmonary vascular resistance during ex vivo lung perfusion (EVLP) ( 33 ) and should be explored in kidney NMP.…”
Section: Discussionmentioning
confidence: 99%